News
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on ...
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment ...
Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside ...
Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia).
Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...
Surrey Hills Holdings terminates employment of founder Pang Gek Teng for ‘wrongdoings and fraud’
SINGAPORE – Ms Pang Gek Teng, who grew Surrey Hills Grocer from one to five outlets, is no longer chief executive (CEO) of Surrey Hills Holdings after it terminated her employment on March 26.
Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia) ...
Copenhagen, DENMARK — Novo Nordisk defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an "important" weight loss treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results